Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2ACITRETIN
02 3ATOVAQUONE
03 1ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
04 1AVAPRO
05 2BANZEL
06 1BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
07 2BOSULIF
08 1CARBAMAZEPINE
09 1CEFADROXIL
10 1CLARITHROMYCIN
11 1CLEOCIN
12 5CLINDAMYCIN PALMITATE HYDROCHLORIDE
13 8DEFERASIROX
14 1DICLOFENAC SODIUM AND MISOPROSTOL
15 1DISULFIRAM
16 1DUAVEE
17 1EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
18 1ENVARSUS XR
19 3ESOMEPRAZOLE MAGNESIUM
20 1FLO-PRED
21 2GLIMEPIRIDE
22 1GONAL-F RFF REDI-JECT
23 3IRBESARTAN
24 3IRBESARTAN AND HYDROCHLOROTHIAZIDE
25 1IRBESARTAN; HYDROCHLOROTHIAZIDE
26 1ITRACONAZOLE
27 1JADENU SPRINKLE
28 1LOVASTATIN
29 1MALARONE
30 1MALARONE PEDIATRIC
31 1MEFLOQUINE HYDROCHLORIDE
32 1MEPRON
33 2METHYLPHENIDATE HYDROCHLORIDE
34 2METOPROLOL SUCCINATE
35 1MIRCERA
36 1NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
37 1NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
38 1NORDITROPIN
39 1NORDITROPIN FLEXPRO
40 1NORDITROPIN NORDIFLEX
41 1ODOMZO
42 2OXYCODONE HYDROCHLORIDE
43 1PRANDIMET
44 1QUILLIVANT XR
45 1RAPAMUNE
46 2REPAGLINIDE
47 1REPAGLINIDE AND METFORMIN HYDROCHLORIDE
48 1SIGNIFOR LAR KIT
49 2SIROLIMUS
50 1SOGROYA
51 2TADALAFIL
52 1TERIL
53 1TRAMADOL HYDROCHLORIDE
54 1VALSARTAN
55 1XERESE
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Drug : NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204206
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213473
Country : US
Patented : No
